Posts Tagged ‘diabetes medicines’

Anticompetitive Pricing for Diabetes and Obesity Drugs

April 4, 2024 — We have much to learn from a recent crisis of escalating insulin prices. This is the bottom line of a new paper in Diabetes Care. In short, multifaceted public policy action eased that crisis. So it has important implications for issues with anticompetitive pricing of diabetes and obesity medicines broadly. Anticompetitive Pricing Practices Authors Kathryn […]